These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1347941)

  • 1. Alpha 1-adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brain.
    Meretyk S; Tang R; Shapiro E; Kyncl JJ; Lepor H
    Prostate; 1992; 20(2):159-65. PubMed ID: 1347941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    J Urol; 1988 Sep; 140(3):664-7. PubMed ID: 2457715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and functional properties of doxazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    Prostate; 1990; 16(1):29-38. PubMed ID: 1968249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
    Hatano A; Tang R; Walden PD; Lepor H
    Eur J Pharmacol; 1996 Oct; 313(1-2):135-43. PubMed ID: 8905340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of displacemental potencies of terazosin enantiomers for alpha 1-adrenoceptor subtypes.
    Maruyama K; Ohkura N; Yagi Y; Nagatomo T
    Biol Pharm Bull; 1994 Aug; 17(8):1126-9. PubMed ID: 7820122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stereospecificity of LY253352 for alpha 1-adrenoceptor binding sites in the brain and prostate.
    Lepor H; Baumann M; Shapiro E
    Br J Pharmacol; 1988 Sep; 95(1):139-44. PubMed ID: 2851347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro.
    Hancock AA; Buckner SA; Ireland LM; Knepper SM; Kerwin JF
    J Recept Signal Transduct Res; 1995; 15(7-8):863-85. PubMed ID: 8673721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.
    Ireland LM; Cain JC; Rotert G; Thomas S; Shoghi S; Hancock AA; Kerwin JF
    Eur J Pharmacol; 1997 May; 327(1):79-86. PubMed ID: 9185839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues.
    O'Malley SS; Chen TB; Francis BE; Gibson RE; Burns HD; DiSalvo J; Bayne ML; Wetzel JM; Nagarathnam D; Marzabadi M; Gluchowski C; Chang RS
    Eur J Pharmacol; 1998 May; 348(2-3):287-95. PubMed ID: 9652345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
    Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
    Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative analyses of human prostatic alpha-adrenoceptors and effects of terazosin on the alpha-adrenoceptor activity].
    Morita T
    J Smooth Muscle Res; 1991 Jun; 27(3):149-54. PubMed ID: 1726720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat.
    Lepor H; Baumann M; Shapiro E
    J Urol; 1987 Nov; 138(5):1336-9. PubMed ID: 2822972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.
    Yamada S; Kato Y; Okura T; Kagawa Y; Kawabe K
    Biol Pharm Bull; 2007 Jul; 30(7):1237-41. PubMed ID: 17603160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.
    Amadesi S; Varani K; Spisani L; Daniele C; Turini A; Agnello G; Zamboni P; Borea PA; Geppetti P
    Prostate; 2001 Jun; 47(4):231-8. PubMed ID: 11398170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
    Lepor H; Gup DI; Baumann M; Shapiro E
    Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.
    Keledjian K; Borkowski A; Kim G; Isaacs JT; Jacobs SC; Kyprianou N
    Prostate; 2001 Jul; 48(2):71-8. PubMed ID: 11433417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
    Muramatsu I; Taniguchi T; Okada K
    Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]bunazosin, a novel selective radioligand of alpha 1 adrenoceptors in human prostates.
    Yamada S; Suzuki M; Matsuoka Y; Kato Y; Kimura R; Maruyama M; Kawabe K
    J Urol; 1991 Sep; 146(3):877-80. PubMed ID: 1714973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
    J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.